COVID-19 Records

Gates Package — page 1208

of 1375 pages

← p.1207 p.1209 → · this page in the original PDF · package

.com> 9PM m> dential and may contain sensitive information. It 2cipient. If you have received this e-mail in error other storage devices. The National Institute of for any statements made that are the sender's representatives. From: "Fauci, Anthony (NIH/NIAID) [E]" @niaid.nih.gov> To: "Bill Gates" @gatesventures.com> Cc: "Melinda French" @mfgates.com> Subject: RE: Our Annual Letter Date: Fri, 29 Jan 2021 14:48:36 -0500 Importance: Normal Thanks, Bill. Anthony S. Fauci, MD Director National Institute of Allergy and Infectious Diseases Building 31, Room 7A-03 31 Center Drive, MSC 2520 National Institutes of Health Bethesda, MD 20892-2520 Phone: FAX: E-mail: @niaid.nih.gov The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own and not expressly made on behalf of the NIAID by one of its representatives. From: Bill Gates @gatesventures.com> Sent: Thursday, January 28, 2021 10:29 PM To: Fauci, Anthony (NIH/NIAID) [E] @niaid.nih.gov> Cc: Melinda French @mfgates.com> Subject: Our Annual Letter Tony, We are writing to share a copy of our 2021 Annual Letter. We decided to focus entirely on the topic at the top of everyone's mind: the pandemic. We hope the letter gives you some reasons for optimism. Bill & Melinda

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/1208

Records on this page

RecordDateTypePages
Our Annual Letter 2021-01-28 email 1208
Our Annual Letter 2021-01-28 email 1207–1208
RE: Our Annual Letter 2021-01-29 email 1208